These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 903333)

  • 1. Susceptibility Bacteroides fragilis to fusidic acid.
    Stirling J; Goodwin S
    J Antimicrob Chemother; 1977 Sep; 3(5):522-3. PubMed ID: 903333
    [No Abstract]   [Full Text] [Related]  

  • 2. Chemotherapy of brain abscess.
    Lancet; 1978 Nov; 2(8099):1081-2. PubMed ID: 82092
    [No Abstract]   [Full Text] [Related]  

  • 3. Bacteraemia due to Bacteroides fragilis with reduced susceptibility to metronidazole.
    Elsaghier AA; Brazier JS; James EA
    J Antimicrob Chemother; 2003 Jun; 51(6):1436-7. PubMed ID: 12746378
    [No Abstract]   [Full Text] [Related]  

  • 4. [Infections caused by Bacteroides fragilis resistant to clindamycin: 2 further cases].
    Andrieu J; Kwantes M; Lapeyrere X; Gardon JD
    Nouv Presse Med; 1978 Feb; 7(7):571-2. PubMed ID: 643586
    [No Abstract]   [Full Text] [Related]  

  • 5. [Bacteriological and clinical studies on metronidazole in Bacteroides fragilis infections (author's transl)].
    Shimada K; Inamatsu T; Sato K
    Jpn J Antibiot; 1979 Feb; 32(2):191-4. PubMed ID: 439390
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bacteroides fragilis septicemia during cefamandole therapy.
    Righter J
    Can Med Assoc J; 1981 Sep; 125(5):422, 424. PubMed ID: 7284925
    [No Abstract]   [Full Text] [Related]  

  • 7. Bacteroides fragilis infections of the urinary tract.
    Garcia JA; Prieto J; Garcia JE; Saenz MC
    J Antimicrob Chemother; 1977 Sep; 3(5):521-2. PubMed ID: 903332
    [No Abstract]   [Full Text] [Related]  

  • 8. Antimicrobial resistance in the Bacteroides fragilis group in faecal microbiota from healthy Danish children.
    Sydenham TV; Jensen BH; Petersen AM; Krogfelt KA; Justesen US
    Int J Antimicrob Agents; 2017 May; 49(5):573-578. PubMed ID: 28366659
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [In vitro and in vivo antimicrobial activities of cefmetazole against Bacteroides fragilis].
    Isono M; Kawashima K; Yamada N; Aoki M; Kobayashi T; Sawa K; Watanabe K; Ueno K
    Jpn J Antibiot; 1982 Jul; 35(7):1667-72. PubMed ID: 6757469
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The underappreciated in vitro activity of tedizolid against Bacteroides fragilis species, including strains resistant to metronidazole and carbapenems.
    Goldstein EJ; Citron DM; Tyrrell KL; Leoncio ES; Merriam CV
    Anaerobe; 2017 Feb; 43():1-3. PubMed ID: 27713022
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Bacteriological studies on Bacteroides fragilis infections and treatment with clindamycin for intravenous injection (author's transl)].
    Tomioka S; Kobayashi Y
    Jpn J Antibiot; 1977 Jan; 30(1):30-5. PubMed ID: 839641
    [No Abstract]   [Full Text] [Related]  

  • 12. Bacteroides fragilis meningitis in a premature infant successfully treated with metronidazole.
    Webber SA; Tuohy P
    Pediatr Infect Dis J; 1988 Dec; 7(12):886-7. PubMed ID: 3211633
    [No Abstract]   [Full Text] [Related]  

  • 13. In vitro bactericidal activities and morphologic changes in Escherichia coli and Bacteroides fragilis by cephalosporins.
    Mikamo H; Kawazoe K; Sato Y; Hayasaki Y; Satoh M; Kai J; Tamaya T
    Chemotherapy; 1998; 44(3):157-63. PubMed ID: 9612605
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Isolation of metronidazole-resistant Bacteroides fragilis carrying the nimA nitroreductase gene from a patient in Washington State.
    Schapiro JM; Gupta R; Stefansson E; Fang FC; Limaye AP
    J Clin Microbiol; 2004 Sep; 42(9):4127-9. PubMed ID: 15364999
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antimicrobial susceptibility testing of Bacteroides fragilis using the MALDI Biotyper antibiotic susceptibility test rapid assay (MBT-ASTRA).
    Justesen US; Acar Z; Sydenham TV; Johansson Å;
    Anaerobe; 2018 Dec; 54():236-239. PubMed ID: 29501419
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibiotic susceptibility profiles of European Bacteroides fragilis with reduced carbapenem susceptibility.
    Hawser SP; Hackel M; Hoban DJ
    J Antimicrob Chemother; 2010 Apr; 65(4):803-4. PubMed ID: 20130025
    [No Abstract]   [Full Text] [Related]  

  • 17. [Etiology, pathogenesis and chemotherapy of Bacteroides infections].
    Poliak MS; Miasnikova LG
    Antibiot Med Biotekhnol; 1985 Feb; 30(2):138-46. PubMed ID: 2860848
    [No Abstract]   [Full Text] [Related]  

  • 18. [Drug resistance of bacteria--the current status and future prospect. 6. Bacteroides].
    Okada J
    Nihon Rinsho; 1984 Mar; 42(3):690-5. PubMed ID: 6471458
    [No Abstract]   [Full Text] [Related]  

  • 19. Comparative in vivo efficiency of cefamandole and cefoxitin against Bacteroides fragilis.
    Bergeron MG; Gauvreau L; Nguyen BM
    Scand J Infect Dis Suppl; 1980; suppl 25():60-5. PubMed ID: 6937954
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Evolution of the sensitivity of Bacteroides group fragilis at the Sevilla University Hospital (1983-1987)].
    Borobio MV; Domínguez MC; Pallares JA; Perea EJ
    Enferm Infecc Microbiol Clin; 1991 Apr; 9(4):214-8. PubMed ID: 1863620
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.